Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
47 studies found for:    ATTRACT
Show Display Options
Rank Status Study
1 Active, not recruiting Evaluation of Cochlear Baha 5 SuperPower Sound Processor on the Baha Attract System
Conditions: Single Sided Sensorineural Deafness;   Mixed Hearing Loss, Unilateral
Intervention: Device: Baha 5 SuperPower on Baha Attract System
2 Terminated The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)
Condition: Arthritis, Rheumatoid
Intervention: Other: Retrospective Chart Review and Data collection
3 Active, not recruiting Post-market Clinical Follow-up of a Magnetic Bone Conduction Implant (Cochlear Baha Attract System)
Conditions: Deafness;   Hearing Loss;   Hearing Loss, Conductive
Intervention: Device: Baha Attract System
4 Active, not recruiting Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis
Conditions: Deep Vein Thrombosis;   Venous Thrombosis;   Postphlebitic Syndrome;   Venous Thromboembolism;   Post Thrombotic Syndrome
Intervention: Drug: Recombinant tissue plasminogen activator (rt-PA)
5 Completed Clinical Performance of a Transcutaneous Bone Conduction Hearing Solution (Baha® Attract System)
Conditions: Deafness;   Hearing Loss;   Hearing Loss, Conductive
Intervention: Device: Baha Attract System
6 Recruiting Efficacy of Aflibercept (Eylea®) on Choroidal Neovascularization (Type 3)
Condition: Type 3 Choroidal Neovascularization
Intervention: Drug: Aflibercept
7 Recruiting Static Magnetic Therapy for Carpal Tunnel Syndrome
Condition: Carpal Tunnel Syndrome
Interventions: Device: Strong Magnetic Wristband;   Device: Weaker Magnetic Wristband
8 Completed
Has Results
CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study
Condition: Papulopustular Rosacea
Interventions: Drug: Ivermectin 1% cream;   Drug: Metronidazole 0.75% cream
9 Recruiting Asian neTwork for Translational Research and Cardiovascular Trials ("ATTRaCT")
Condition: Heart Failure
Interventions: Other: Cardiovascular Magnetic Resonance Imaging (CMRI);   Other: Electrocardiogram (ECG);   Other: Blood Sample Collection;   Other: Clinical Assessment;   Other: Cardiovascular Ultrasound (CVUS);   Other: Cognitive Test
10 Terminated A Study of ASA404 or Placebo in Combination With Docetaxel in Second-line Treatment for (Stage IIIb/IV) Non-small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: ASA404;   Drug: Placebo;   Drug: docetaxel
11 Completed
Has Results
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients
Conditions: Neurotoxicity;   Pain;   Peripheral Neuropathy;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: ketamine/amitriptyline NP-H cream;   Other: placebo
12 Completed A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)
Condition: Arthritis, Rheumatoid
Interventions: Other: Placebo;   Drug: MTX;   Biological: Infliximab
13 Completed A Double Blind Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Frovatriptan in the Acute Treatment of Migraine
Condition: Migraine
Intervention: Drug: Frovatriptan
14 Completed Intra-uterine Injection of Human Chorionic Gonadotrophin (hCG) Before Embryo Transfer
Condition: Infertility
Intervention: Drug: human chorionic gonadotrophin
15 Terminated Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer
Conditions: Transitional Cell Carcinoma;   Bladder Cancer;   Carcinoma in Situ;   Carcinoma in Situ Concurrent With Papillary Tumors
Interventions: Biological: CG0070 adenovirus vector;   Other: Control Arm: Quadruple Choice
16 Completed Incentives in Diabetic Eye Assessment by Screening
Conditions: Diabetes;   Diabetic Retinopathy
Interventions: Behavioral: Fixed financial incentive;   Behavioral: Probabilistic financial incentive;   Behavioral: Control
17 Completed NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)
Condition: Malignant Melanoma
Interventions: Biological: NY-ESO-1 protein;   Drug: Imiquimod
18 Completed Prediction of Acute Rejection in Renal Transplant
Condition: Kidney Transplant
Intervention:
19 Completed Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant Recipients
Condition: Influenza
Intervention:
20 Recruiting Does Acetylsalicylic Acid Reduce the Mortality of Patients Admitted to an Intensive Care Unit
Condition: Critical Illness
Interventions: Drug: Acetylsalicylic acid lysinate;   Drug: 0.9% sodium-chloride solution

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.